TD Securities upgraded shares of Vitalhub (TSE:VHI – Free Report) to a strong-buy rating in a report released on Monday morning,Zacks.com reports.
Separately, Cormark lifted their price target on Vitalhub from C$9.50 to C$10.50 and gave the stock a “buy” rating in a report on Wednesday, October 2nd.
Read Our Latest Research Report on Vitalhub
Vitalhub Price Performance
About Vitalhub
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
Further Reading
- Five stocks we like better than Vitalhub
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Canadian Penny Stocks: Can They Make You Rich?
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.